Related references
Note: Only part of the references are listed.Kinase requirements in human cells: I. Comparing kinase requirements across various cell types
Dorre A. Grueneberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations
Lianjie Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The !von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells
Benedetta Peruzzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma
N Nakaigawa et al.
CANCER RESEARCH (2006)
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
J Moffat et al.
CELL (2006)
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer
K Smith et al.
CANCER RESEARCH (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
Global mapping of the yeast genetic interaction network
AHY Tong et al.
SCIENCE (2004)
From large networks to small molecules
JR Sharom et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Combining biological networks to predict genetic interactions
SL Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300
NL Sang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lentivirus-delivered stable gene silencing by RNAi in primary cells
SA Stewart et al.
RNA (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1α
E Hur et al.
MOLECULAR PHARMACOLOGY (2001)
Role of transforming growth factor-α in von Hippel-Lindau (VHL)-/- clear cell renal carcinoma cell proliferation:: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis
N de Paulsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
